Trudy Owens

Trudy Owens

Auto-generated profile, based on publicly available information

Trudy Owens

School of Economics, University of Nottingham, Nottingham, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2011 in Neurology
Verified
Journal Article
Closed access
PDF file
ETE.C. Tallantyre
E.C. Tallantyre
JDJ.E. Dixon
J.E. Dixon
IDI. Donaldson
I. Donaldson
TOT. Owens
T. Owens
PMP.S. Morgan
P.S. Morgan
NEN. Evangelou
N. Evangelou
Objectives: To investigate whether multiple sclerosis (MS) and non-MS white matter brain lesions can be distinguished by their appearance on 7 T T2*-weighted MRI. Methods: This was an observational study of 28 patients with MS and 17 patients with cerebral white matter lesions who did not have MS. Subjects were imaged using 7 T T2*-weighted imaging. White matter lesions were identified and analyzed for volume, location, and perivenous appearance. Results: Out of 901 lesions identified in patients with MS, 80% were perivenous. In comparison, 19% of 428 lesions identified in patients without MS had a perivenous appearance. Seven-Tesla T2*-weighted MRI reliably distinguished all patients with clinically definite MS (>40% lesions appeared perivenous) from those without clinical MS (<40% lesions appeared perivenous). Perivenous lesion appearance was more predictive of MS (odds ratio [OR] 14, p < 0.001) than subcortical or periventricular lesion location (OR 4.5, p < 0.001, and OR 2.4, p = 0.009). Perivenous lesion appearance was observed with a similar frequency in patients with clinically isolated syndrome of demyelination and in early (gadolinium-enhancing) MS lesions. Conclusion: Perivenous lesion location on 7 T T2*-weighted imaging is predictive of the presence of demyelination. Optimization of this imaging technique at lower magnetic resonance field strengths would offer benefit for the diagnosis of MS.

1 February 2009 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
CGC P Gilmore
C P Gilmore
IDI Donaldson
I Donaldson
LBL Bo
L Bo
TOT Owens
T Owens
JLJ Lowe
J Lowe
NEN Evangelou
N Evangelou
Background: Substantial grey matter (GM) demyelination occurs in both the cerebral cortex and spinal cord in multiple sclerosis (MS). GM demyelination also occurs in the cerebellar cortex and the deep GM nuclei of the brain. However, no study has made a direct “within subject” comparison of the extent of GM pathology between these regions. Aim: To examine the extent and pattern of GM demyelination in the motor cortex, cingulate gyrus, cerebellum, thalamus and spinal cord in MS. Methods: Postmortem study using material from 14 MS cases and three controls. Sections were taken from the five predetermined areas and stained for proteolipid protein. The extent of GM and white matter (WM) demyelination was assessed in each region. Results and conclusion: Overall, 28.8% of the GM was demyelinated compared with 15.6% of the WM (p<0.001), with demyelination being greater in the GM than in the WM at each of the anatomical sites. There was substantial variation in the extent of demyelination between the different CNS regions. GM demyelination was most extensive in the spinal cord and cerebellum while WM demyelination was most prominent in the spinal cord.

9 March 2010 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
PDF file
ETEmma C Tallantyre
Emma C Tallantyre
LBLars Bø
Lars Bø
OAOmar Al-Rawashdeh
Omar Al-Rawashdeh
TOTrudy Owens
Trudy Owens
CPChris H Polman
Chris H Polman
NENikos Evangelou
Nikos Evangelou
Growing evidence suggests that axonal degeneration rather than demyelination is the pathological substrate underlying chronic, irreversible disability in multiple sclerosis. However, direct evidence linking clinical disability measured in vivo with corresponding post-mortem measures of axonal pathology is lacking. Our objective in this study was to investigate the relationship between motor disability accumulated by patients with multiple sclerosis during life and the degree of axonal loss observed in their descending motor tracts after death. Human spinal cord derived at autopsy from 45 patients with multiple sclerosis was investigated. The medical records of each patient were reviewed by a multiple sclerosis neurologist to determine the degree of motor disability reached before death. Spinal cord sections were stained immunohistochemically. The degree of demyelination and the number of surviving corticospinal tract axons were measured in each patient. Patients who had accumulated higher levels of motor disability prior to death demonstrated fewer surviving corticospinal axons. Motor disability did not correlate with degree of demyelination. This study provides for the first time, direct clinico-pathological evidence that axonal loss is the pathological substrate of established disability in multiple sclerosis.


1 January 2003 in Economic Development and Cultural Change
Verified
Journal Article
Closed access
TOTrudy Owens
Trudy Owens
JHJohn Hoddinott
John Hoddinott
BKBill Kinsey
Bill Kinsey
Journal articleISI; IFPRI3; GRP26; Theme 8FCNDP

1 July 2006 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
CGChristopher P. Gilmore
Christopher P. Gilmore
LBLars Bö
Lars Bö
TOTrudy Owens
Trudy Owens
JLJames Lowe
James Lowe
MEMargaret M. Esiri
Margaret M. Esiri
NENikos Evangelou
Nikos Evangelou